Miotto · FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2019 · randomized controlled trial · n=20

Supplementation with dietary ω-3 mitigates immobilization-induced reductions in skeletal muscle mitochondrial respiration in young women.

Cited 60 times in the scientific literature.

Level 2 - randomized trial

Individual randomized controlled trial

PubMed 30970218 · doi:10.1096/fj.201900095R · record verified 2026-08-30

What was done

Healthy young women (n = 20, age 22 ± 3 years) were randomized to receive either control (n = 9) or omega-3 supplementation (n = 11; 3 g EPA and 2 g DHA daily) for 4 weeks prior to and during 2 weeks of single-limb immobilization. Muscle biopsies were performed before immobilization and at days 3 and 14 of immobilization to assess mitochondrial respiration, H2O2 emission, and markers of ADP transport and lipid metabolism.

What was found

In the control group, 3 days of immobilization reduced ADP-stimulated mitochondrial respiration by ~20% without changes in ADP sensitivity or mitochondrial protein abundance; at 14 days, respiration remained reduced and mitochondrial proteins were reduced by ~20%. Omega-3 supplementation prevented both the reduction in mitochondrial respiration and the loss of mitochondrial content across the 14 days. Neither immobilization nor supplementation altered mitochondrial H2O2 emission (with or without ADP), cellular redox markers, lipid-supported respiration, or lipid metabolic proteins.

Why it matters

The findings demonstrate that disuse-induced mitochondrial respiration defects occur rapidly before protein loss and that high-dose omega-3 supplementation can preserve mitochondrial oxidative phosphorylation capacity during limb immobilization.

Limits

The study had a small sample size (n = 20) and included only healthy young females, limiting direct translation to older populations, males, or clinical patients experiencing systemic disuse or illness-related muscle wasting.

Cited by